LOGIN  |  REGISTER
C4 Therapeutics

Becton Dickinson (NYSE: BDX) Stock Quote

Last Trade: US$235.65 0.34 0.14
Volume: 1,793,642
5-Day Change: -4.29%
YTD Change: -3.35%
Market Cap: US$68.080B

Latest News From Becton Dickinson

HealthStocksHub
First Patient Enrollment in AGILITY Study Begins Investigations of Safety and Effectiveness of BD Vascular Covered Stent for Treatment of PAD FRANKLIN LAKES, N.J. , March 4, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the enrollment of the... Read More
FRANKLIN LAKES, N.J. , Feb. 27, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Dave Hickey has informed the company of his intent to retire from BD, effective July 1 . Hickey is currently executive vice president and president of the Life Sciences segment for BD, a position he has held since January 2021 . Prior to his current role,... Read More
HealthStocksHub
First-Ever Program in the Country to Offer At-Home Self-Collection of Samples for HPV Testing SINGAPORE , Feb. 21, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a strategic partnership with Camtech Health, a digital health company focused on... Read More
FRANKLIN LAKES, N.J. , Feb. 15, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the following healthcare conferences: Citi's 2024 Unplugged Medtech and Life Sciences Access Day February 29, 2024 8:00 am Eastern Time Barclays 26 th Annual Global Healthcare Conference March 13, 2024 9:30 am Eastern Time The live webcasts... Read More
FRANKLIN LAKES, N.J. , Feb. 12, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present the next installment of its BD Innovates series — which will highlight BD solutions that help clinicians treat Peripheral Vascular Disease — on Monday, February 26, 2024 , at 3:00 PM Eastern Time . The BD Innovates series spotlights BD's... Read More
Margin Execution Drives Better Performance in Quarter and Higher Guidance for Fiscal 2024 Q1 revenue of $4.7 billion increased 2.6% as reported, 1.6% currency-neutral and 2.4% organic Q1 GAAP and adjusted diluted EPS from continuing operations of $0.96 and $2.68 , respectively Company raises full-year adjusted EPS guidance and midpoint of organic revenue growth guidance FRANKLIN LAKES, N.J. , Feb. 1, 2024 /PRNewswire/ -- BD... Read More
HealthStocksHub
AI-Based Algorithm Aims to Enable Cytotechnologists and Pathologists to Efficiently Identify Evidence of Cervical Cancer and Precancerous Lesions FRANKLIN LAKES, N.J. and OREM, Utah , Jan. 30, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Techcyte, a world... Read More
Collaboration with Kenya Ministry of Health National Cancer Institute Aims to Expand Access to Diagnostics, Reduce Cervical Cancer Rates NAIROBI, Kenya , Jan. 25, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a collaboration with the Kenyan Government through the National Cancer Institute-Kenya to advance access to critical cancer diagnostics... Read More
FRANKLIN LAKES, N.J. , Jan. 23, 2024 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has declared a quarterly dividend of $0.95 per common share, payable on March 29, 2024 to holders of record on March 8, 2024 . The indicated annual dividend rate is $3.80 per share. About BD BD is one of the largest global medical... Read More
HealthStocksHub
Companies to automate a critical step of high-throughput single-cell multiomics experiments FRANKLIN LAKES, N.J. , Jan. 23, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced a collaboration agreement with Hamilton, a leading global manufacturer of... Read More
HealthStocksHub
Survey Conducted in the US, UK and Sweden Exposes Lack of Education on Options and Unclear Guidance on HPV Testing FRANKLIN LAKES, N.J. , Jan. 10, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the results of a Harris Poll survey of women in the... Read More
FRANKLIN LAKES, N.J. , Jan. 5, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will host a live webcast of its Annual Meeting of Shareholders on Tuesday, January 23, 2024 , at 1:00 p.m. (ET) . The audio webcast can be accessed at BD's investor relations website at www.bd.com/investors and a replay will be available shortly after the... Read More
FRANKLIN LAKES, N.J. , Jan. 4, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial results for its first quarter of fiscal year 2024 on Thursday, February 1, 2024 . A news release will be issued at approximately 6:30 a.m. Eastern Time (ET) and will be available at www.bd.com/investors , along with related presentation... Read More
FRANKLIN LAKES, N.J. , Dec. 22, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the 42 nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024 at 10:30 am Eastern Time . The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com . A replay of the event... Read More
HealthStocksHub
Company Reinforces its Longstanding Commitment to Help Improve Health Equity and Expand Access to Care Among Vulnerable Populations FRANKLIN LAKES, N.J. , Dec. 11, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it signed the World Economic... Read More
HealthStocksHub
BD MiniDraw™ Capillary Blood Collection System Enables Lab-Quality Blood Testing from Less Invasive Method than Venous Collection in More Convenient Locations FRANKLIN LAKES, N.J. , Dec. 7, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has... Read More
FRANKLIN LAKES, N.J. , Dec. 4, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present the next installment of its BD Innovates series, which will highlight its Pharmaceutical Systems business on Monday, December 11, 2023 , at 11:30 am Eastern Time . The BD Innovates series spotlights BD's innovation, products and pipeline in... Read More
HealthStocksHub
Company Committed to Support U.S. Health Care Needs FRANKLIN LAKES, N.J. , Nov. 30, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement regarding the U.S. Food and Drug Administration (FDA) Safety Communication on evaluation of... Read More
HealthStocksHub
SiteRite™ 9 Ultrasound System Delivers Enhanced Image Quality and Vessel Assessment Tools to Aid in First Attempt IV Insertion Success FRANKLIN LAKES, N.J. , Nov. 30, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today launched a new, advanced ultrasound... Read More
FRANKLIN LAKES, N.J. , Nov. 21, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Ronald (Ron) Silverman , MD, FACS, has been named executive vice president and chief medical officer of BD, effective Dec. 4, 2023 . Dr. Silverman will be responsible for leading the company's Medical Affairs organization, which includes end-to-end medical... Read More
FRANKLIN LAKES, N.J. , Nov. 14, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the 6 th Annual Evercore ISI HealthCONx Conference on Tuesday, November 28, 2023 at 8:20 am Eastern Time . The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com . A replay of the event... Read More
Execution of BD 2025 Strategy Driving Durable, Broad-Based Growth Q4 revenue of $5.1 billion increased 6.8% as reported and 5.9% on a currency-neutral basis Q4 revenue from base business (which excludes COVID-only diagnostic testing) grew 7.3% as reported, 6.3% currency-neutral or 7.0% organic Q4 GAAP and adjusted diluted EPS from continuing operations of $0.53 and $3.42 , respectively FY23 revenue of $19.4 billion increased... Read More
FRANKLIN LAKES, N.J. , Nov. 9, 2023 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.95 per common share, an increase of 4.4% from the previous quarter. The dividend will be payable on December 29, 2023 to holders of record on December 8, 2023 . The indicated annual dividend rate for fiscal year 2024 is $3.80 per share. "This is the 52nd... Read More
HealthStocksHub
New Peripheral Line Draw Solution Delivers First and Only Compatibility with Integrated Catheters, Bringing Elevated Standard of Care to More U.S. Hospitals FRANKLIN LAKES, N.J. , Nov. 2, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today launched new... Read More
Company Ranks Top 2 in Healthcare Equipment and Services Industry FRANKLIN LAKES, N.J. , Oct. 18, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has been named to the 100 Best Corporate Citizens List by 3BL, which recognizes outstanding environmental, social and governance (ESG) transparency and performance among 1,000 of the largest U.S.... Read More
FRANKLIN LAKES, N.J. , Oct. 17, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced Greg Rodetis , currently BD senior vice president and treasurer will also add head of investor relations to his responsibilities, effective immediately. In this expanded role, Greg will continue as company treasurer and also lead all aspects of communicating... Read More
All Used Injection Devices Recycled; Next Stage of Pilot to Expand Regionally, Add Medical Devices FRANKLIN LAKES, N.J. and RUTLAND, Vt . , Oct. 16, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Casella Waste Systems, Inc. (Nasdaq: CWST) (Casella), a solid waste, recycling, and resource management services company, today announced the most recent results... Read More
FRANKLIN LAKES, N.J. , Oct. 12, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced that it will report its fiscal 2023 fourth quarter and full year financial results on Thursday, November 9, 2023 . A news release will be issued at approximately 6:30 a.m. Eastern Time (ET) and will be available at www.bd.com/investors , along with related... Read More
Recognition underscores company's commitment to transparency and values FRANKLIN LAKES, N.J. , Sept. 19, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has been ranked in the top 10 for overall transparency and awarded Best Code of Conduct among S&P 250 companies in the fifth annual U.S. Transparency Awards by Labrador, a global... Read More
CARLSBAD, Calif. , Sept. 7, 2023 /PRNewswire/ -- Navigate BioPharma Services, Inc. , a specialty laboratory offering high-quality, innovative precision medicine solutions and bioanalytics for clinical development and diagnostic applications, announces a strategic collaboration with BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, to explore opportunities to develop and commercialize... Read More
FRANKLIN LAKES, N.J. , Aug. 23, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the following healthcare conferences: 2023 Wells Fargo Healthcare Conference September 6, 2023 8:45 a.m. EDT Morgan Stanley 21 st Annual Global Healthcare Conference September 12, 2023 8:50 a.m. EDT The live webcasts of BD's presentations can... Read More
Continues Strong Performance and Progress Toward Achieving BD 2025 Strategy; Advances Innovation Pipeline and Receives Clearance for Updated BD Alaris™ Infusion System Revenue of $4.9 billion increased 5.1% as reported and 6.3% on a currency-neutral basis Revenue from base business (which excludes COVID-only diagnostic testing) grew 6.7% as reported, 7.9% currency-neutral or 6.3% organic GAAP and adjusted diluted EPS from... Read More
HealthStocksHub
Single Test on BD MAX™ System Identifies and Differentiates Multiple Respiratory Infectious Diseases from One Sample FRANKLIN LAKES, N.J. , Aug. 1, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced U.S. Food and Drug Administration (FDA) 510(k)... Read More
FRANKLIN LAKES, N.J. , July 25, 2023 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.91 per common share, payable on September 29, 2023 to holders of record on September 8, 2023 . The indicated annual dividend rate is $3.64 per share. About BD BD is one of the largest global medical technology companies in the world and is advancing the world of... Read More
FRANKLIN LAKES, N.J. , July 24, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment of Dr. Joanne Waldstreicher to its board of directors. Waldstreicher, 63, was most recently the chief medical officer for Johnson & Johnson (J&J), serving in this capacity from 2012 until her retirement in 2023. As chief medical officer, she provided... Read More
FRANKLIN LAKES, N.J. , July 24, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) Chairman, CEO and President Tom Polen issued the following message regarding the U.S. Food and Drug Administration (FDA) 510(k) clearance for the updated BD Alaris™ Infusion System : "Hello, I'm Tom Polen , chairman, CEO and president of BD. I wanted to share some exciting news and explain what it means for our company and our... Read More
HealthStocksHub
BD Alaris™ Infusion System is the only modular and most comprehensive infusion system on the U.S. market that includes large volume pumps, syringe pumps, patient-controlled analgesia (PCA) pumps, respiratory monitoring, auto-identification, dose error reduction software and EMR interoperability BD Alaris™ Infusion System's... Read More
HealthStocksHub
Company Expands its ESG Focus Areas to Include Advancing Health Equity in Under-Resourced Communities FRANKLIN LAKES, N.J. , July 20, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued its Fiscal Year 2022 Environmental, Social and Governance (ESG)... Read More
Top Score on Disability Equality Index Demonstrates Ongoing Progress in Creating Employment Opportunities for People with Disabilities FRANKLIN LAKES, N.J. , July 11, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its recognition as a Best Place to Work for Disability Inclusion for the fifth consecutive year. This marks BD's second consecutive... Read More
FRANKLIN LAKES, N.J. , July 6, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial results for its third quarter of fiscal year 2023 on Thursday, August 3, 2023 . A news release will be issued at approximately 6:30 a.m. Eastern Time (ET) and will be available at www.bd.com/investors , along with related presentation... Read More
Divestiture Advances BD2025 Strategy to Simplify Portfolio and Focus on Higher-Growth Markets FRANKLIN LAKES, N.J. , June 20, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has signed a definitive agreement to sell its Surgical Instrumentation platform to STERIS (NYSE: STE) for $540 million . The divestiture will include V. Mueller™,... Read More
HealthStocksHub
BD FACSDuet™ Premium System Leverages Robotics to Automate Sample Preparation for Greater Standardization in Clinical Flow Cytometry Diagnostics FRANKLIN LAKES, N.J. , June 12, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the worldwide commercial... Read More
HealthStocksHub
BD PosiFlush™ SafeScrub Streamlines Clinical Workflow for Disinfecting and Flushing IV Catheters to Help Improve Patient Care FRANKLIN LAKES, N.J. , May 23, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced expanded customer availability of an all-in-one... Read More
HealthStocksHub
BD FACSDiscover™ S8 Cell Sorter First to Combine Spectral Flow Cytometry with Real-Time Imaging Technology FRANKLIN LAKES, N.J. , May 18, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the worldwide commercial launch of a new-to-world cell sorting... Read More
HealthStocksHub
BD Kiestra™ MRSA Imaging Application Helps Enhance Microbiology Laboratory Efficiency and Workflow FRANKLIN LAKES, N.J. , May 16, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced 510(k) clearance from the U.S. Food and Drug Administration (FDA)... Read More
Five organizations are collaborating to evaluate recycling program for blood collection tubes at Odense University Hospital COPENHAGEN, Denmark , May 8, 2023 /PRNewswire/ -- A new health care sector collaboration in Denmark will evaluate the feasibility of recycling used blood collection tubes to reduce medical waste as part of the participants' sustainability goals and Denmark's Climate Action Strategy. The pilot program is... Read More
BD 2025 Strategic Investments Driving Growth and Advancing Innovation; Company Raises Mid-point of Revenue and Adjusted EPS Guidance Ranges Revenue of $4.8 billion increased 1.5% as reported and 4.1% on a currency-neutral basis Revenue from base business (which excludes COVID-only diagnostic testing) grew 6.0% as reported, 8.7% currency-neutral GAAP and adjusted diluted EPS from continuing operations of $1.53 and $2.86 ,... Read More
FRANKLIN LAKES, N.J. , May 3, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has been named a "Noteworthy Company" in DiversityInc's annual ranking of the top U.S. companies for diversity. Since 2001, the DiversityInc Top 50 survey has been the external validator for large U.S. employers that model fairness in their talent strategy,... Read More
FRANKLIN LAKES, N.J. , April 26, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Bank of America Securities 2023 Health Care Conference on Tuesday, May 9, 2023 at 11:00 am Eastern Time . The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com . A replay of the... Read More
FRANKLIN LAKES, N.J. , April 25, 2023 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.91 per common share, payable on June 30, 2023 to holders of record on June 9, 2023 . The indicated annual dividend rate is $3.64 per share. About BD BD is one of the largest global medical technology companies in the world and is advancing the world of health... Read More
Accolade Represents Positive Perceptions from Employees and Progress in Advancing ESG Strategy FRANKLIN LAKES, N.J. , April 25, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has been recognized by Forbes as one of the leading employers in the U.S. for diversity. BD was named to the list based on survey responses from approximately... Read More
HealthStocksHub
FRANKLIN LAKES, N.J. , April 19, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today released findings from a survey conducted online by The Harris Poll, reporting that women feel less knowledgeable about testing and treatment options for sexually transmitted... Read More
HealthStocksHub
BD Prevue™ II System Equips Clinicians with Connected Ultrasound Technology to Drive More Intuitive IV Placement and Control FRANKLIN LAKES, N.J. , April 11, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today launched a new, easy-to-use advanced ultrasound... Read More
FRANKLIN LAKES, N.J. , April 6, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial results for its second quarter of fiscal year 2023 on Thursday, May 4, 2023 . A news release will be issued at approximately 6:30 a.m. Eastern Time (ET) and will be available at www.bd.com/investors , along with related presentation... Read More
HealthStocksHub
FRANKLIN LAKES, N.J. , April 3 , 2023 BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Michelle Quinn has been named executive vice president and general counsel for the company, effective April 1 . Quinn has responsibility for leading the Law Group at BD. She... Read More
HealthStocksHub
BD Vaginal Panel on BD COR™ System Tests for Multiple Common Types of Vaginitis Using Only One Swab, One Test FRANKLIN LAKES, N.J. , March 16, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has received 510(k) clearance from the U.S.... Read More
FRANKLIN LAKES, N.J. , March 1, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Barclays Global Healthcare Conference on Wednesday, March 15, 2023 at 9:00 am Eastern Time . The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com . A replay of the event will be... Read More
HealthStocksHub
The 3 rd Generation BD Kiestra™ Total Lab Automation System Offers Flexible Instrument to Optimize Lab Space and Streamline Workflow FRANKLIN LAKES, N.J. , Jan. 11, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today introduced a new, robotic track system for... Read More
HealthStocksHub
Assay for Research and Clinical Use Now Globally Available for the BD MAX™ System FRANKLIN LAKES, N.J. , Jan. 9, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and CerTest Biotec have announced Emergency Use Authorization (EUA) from the U.S. Food and Drug... Read More
FRANKLIN LAKES, N.J. , Jan. 6, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will host a live webcast of its Annual Meeting of Shareholders on Tuesday, January 24, 2023 , at 1 p.m. (ET) . The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com . A replay of the event will be... Read More
HealthStocksHub
FRANKLIN LAKES, N.J. , Jan. 6, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Michelle Quinn has been named acting general counsel of BD, succeeding Samrat (Sam) Khichi , who has informed the company of his intent to depart BD for a new... Read More
FRANKLIN LAKES, N.J. , Jan. 5, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial results for its first quarter of fiscal year 2023 on Thursday, February 2, 2023 . A news release will be issued at approximately 6:30 a.m. Eastern Time (ET) and will be available at www.bd.com/investors , along with related presentation... Read More
HealthStocksHub
FRANKLIN LAKES, N.J. , Jan. 5, 2023 /PRNewswire/ -- BD (Becton , Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today released findings from a survey conducted by The Harris Poll, between Nov. 14-16, 2022 , among 872 U.S. women ages 18 to 64 years old, that indicate a significant gap in... Read More
FRANKLIN LAKES, N.J. , Dec. 20, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the 41 st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023 at 12:45 pm Eastern Time . The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com . A replay of the event... Read More
HealthStocksHub
FRANKLIN LAKES, N.J. , Dec. 8, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the release of its second annual Global Inclusion, Diversity and Equity (ID&E) Report for fiscal year 2022. The report, titled "We are the makers of possible," is an... Read More
FRANKLIN LAKES, N.J. , Dec. 7, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has been named among the top 25% of Newsweek's list of America's Most Responsible Companies. This is the fourth consecutive year that the company has been named to the list. The list recognizes the top 500 most responsible companies in the U.S. based on... Read More

COPYRIGHT ©2023 HEALTH STOCKS HUB